PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3.29%
EBIT growth below 50% of CRVO's 100.00%. Michael Burry would suspect deeper competitive or cost structure issues.
3.29%
Operating income growth under 50% of CRVO's 100.00%. Michael Burry would be concerned about deeper cost or sales issues.
27.01%
Net income growth under 50% of CRVO's 100.00%. Michael Burry would suspect the firm is falling well behind a key competitor.
26.90%
EPS growth under 50% of CRVO's 100.00%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
26.90%
Diluted EPS growth under 50% of CRVO's 100.00%. Michael Burry would worry about an eroding competitive position or excessive dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3.31%
OCF growth under 50% of CRVO's 100.00%. Michael Burry might suspect questionable revenue recognition or rising costs.
3.31%
FCF growth under 50% of CRVO's 100.00%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-12.36%
Negative 10Y OCF/share CAGR while CRVO stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-12.36%
Negative 5Y OCF/share CAGR while CRVO is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-12.36%
Negative 3Y OCF/share CAGR while CRVO stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
44.63%
10Y net income/share CAGR of 44.63% while CRVO is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
44.63%
Net income/share CAGR of 44.63% while CRVO is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
44.63%
3Y net income/share CAGR of 44.63% while CRVO is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
-80.42%
Negative equity/share CAGR over 10 years while CRVO stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-80.42%
Negative 5Y equity/share growth while CRVO is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-80.42%
Negative 3Y equity/share growth while CRVO is at 0.00%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.02%
Asset growth of 0.02% while CRVO is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
-16.23%
We have a declining book value while CRVO shows 100.00%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
14.30%
Debt shrinking faster vs. CRVO's 3215.72%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
No Data
No Data available this quarter, please select a different quarter.
-4.62%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.